Testing effectiveness (Phase 2)UnknownNCT02224547
What this trial is testing
Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System
Who this might be right for
Non-Small Cell Lung Carcinoma
Universitair Ziekenhuis Brussel 58